title: [Long-term results and prognostic factors of squamous cell carcinoma of the anal canal treated by irradiation].
abstract: OBJECTIVE
  To analyze the prognostic factors of loco regional control (LRC), specific survival (SS) and sphincter conservation (SC) of patients treated by curative and conservative irradiation for an epidermoid cancer of anal canal in our institution.
  
  
  METHODS
  From 1976 to 2005, 286 patients (pts) were treated by exclusive radiotherapy (180 pts) or chemo-radiotherapy (106 pts) followed by a brachytherapy boost (233 pts) or external beam radiotherapy boost (24 pts). Forty-three pts were stage I, 154 stage II, 31 stage IIIA and 53 stage IIIB.
  
  
  RESULTS
  The mean follow-up was 65 months (range: 1.3-250 months). The 5-years-overall survival and SS rates were 66.4% and 78.1% respectively. In multivariate analysis, tumor size (>or=40 mm) [RR=2.1], node involvement (RR=2.4), and poor response (<75%) to first course irradiation [RR=1.9], local relapse (RR=4.5) and distant metastases were factors of poor prognosis for SS. Five-years-LRC were 71.5% (88% for stage I, 69% for stage II, 77%, for stage IIIA and 60% for stage IIIB). Prognosis factors of LCR were tumor size (RR=2.5), response to first course of irradiation (RR=2.9). SC was 71% at 5 years. Prognosis factors of SC were tumor size (RR=1.9) and response to first course of irradiation (RR=2.4).
  
  
  CONCLUSIONS
  The results of this series are similar to those of the literature. As well as initial tumor extension, response to first course of irradiation was found as prognostic factor on LCR, SS, SC. Our results are similar to other series and brachytherapy seems not to be deleterious. Its impact to local control remains to be evaluated.
authors.affiliation: Département de radiothérapie et curiethérapie, centre Alexis-Vautrin, avenue de Bourgogne, 54511 Vandoeuvre-lès-Nancy cedex, France. l.tournier@nancy.fnclcc.fr
authors.forename: L
authors.initials: L
authors.lastname: Tournier-Rangeard
authors.forename: D
authors.initials: D
authors.lastname: Peiffert
authors.forename: C
authors.initials: C
authors.lastname: Lafond
authors.forename: A
authors.initials: A
authors.lastname: Mege
authors.forename: Y
authors.initials: Y
authors.lastname: Metayer
authors.forename: V
authors.initials: V
authors.lastname: Marchesi
authors.forename: I
authors.initials: I
authors.lastname: Buchheit
authors.forename: L
authors.initials: L
authors.lastname: Uwer
authors.forename: T
authors.initials: T
authors.lastname: Conroy
authors.forename: M-C
authors.initials: MC
authors.lastname: Kaminsky
mesh_terms: D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D001005:Anus Neoplasms / Q000401:mortality / Q000532:radiotherapy*; D002294:Carcinoma, Squamous Cell / Q000401:mortality / Q000532:radiotherapy*; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D008297:Male; D008875:Middle Aged; D011379:Prognosis; D015996:Survival Rate; D013997:Time Factors